Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.
Matthew J TunbridgeGriffith B PerkinsJulian SingerTania SalehiTracey YingBranka Grubor-BaukSimon BarryBeatrice SimPravin HissariaSteven J ChadbanP Toby CoatesPublished in: Trials (2022)
Australia New Zealand Clinical Trials Registry ACTRN12621001412820. Registered on 20 October 2021; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382891&isReview=true.